Exercise in neuromuscular diseases

Physical Medicine and Rehabilitation Clinics of North America

Volumn 23, Issue 3, 2012, Pages 653-673

  Abresch, R Ted ^a   Carter, Gregory T ^a   Han, Jay J ^a   McDonald, Craig M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exercise therapy; Muscular dystrophies; Neuromuscular disease; Randomized controlled trials

Indexed keywords

AEROBIC EXERCISE; AMYOTROPHIC LATERAL SCLEROSIS; BONE MASS; CARDIOPULMONARY FUNCTION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DYSTROPHINOPATHY; EVIDENCE BASED MEDICINE; FASCIOSCAPULOHUMERAL DYSTROPHY; FUNCTIONAL STATUS; HEREDITARY MOTOR SENSORY NEUROPATHY; KINESIOTHERAPY; LIMB GIRDLE MUSCULAR DYSTROPHY; MITOCHONDRIAL MYOPATHY; MOTOR NEURON DISEASE; MULTICENTER STUDY (TOPIC); MUSCLE INJURY; MUSCULAR DYSTROPHY; MYOSITIS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; OBESITY; OUTCOME ASSESSMENT; OVERWORK INJURY; PERIPHERAL NEUROPATHY; PHYSICAL ACTIVITY; POSTPOLIOMYELITIS SYNDROME; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; VALIDATION STUDY; WELLBEING;

EXERCISE; EXERCISE THERAPY; HUMANS; MITOCHONDRIAL MYOPATHIES; MOTOR NEURON DISEASE; MUSCULAR DYSTROPHIES; MYOSITIS; NEUROMUSCULAR DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEDENTARY LIFESTYLE;

EID: 84865567343     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2012.06.001     Document Type: Review

References (124)

1. Chamberlain J.S., Rando T.A. Duchenne muscular dystrophy: advances in therapeutics. Neurological disease and therapy 2006, Taylor & Francis, New York, xxii, p. 461.
2. Fowler W.M. Management of musculoskeletal complications in neuromuscular diseases: weakness and the role of exercise. Phys Med Rehabil 1988, 2:489-504.
3. Fowler W.M. Role of physical activity and exercise training in neuromuscular diseases. Am J Phys Med Rehabil 2002, 81:S187-S195.
4. Fowler W.M., Taylor M. Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise. Arch Phys Med Rehabil 1982, 63:319-321.
5. Matheson G.O., Klügl M., Dvorak J., et al. Responsibility of sport and exercise medicine in preventing and managing chronic disease: applying our knowledge and skill is overdue. Br J Sports Med 2011, 45(16):1272-1282. [Epub 2011 Sep 26].
6. Tremblay M.S., Warburton D.E., Janssen I., et al. New Canadian physical activity guidelines. Appl Physiol Nutr Metab 2011, 36(1):36-46. 47-58.
7. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995, 273:402-407.
8. Zinna E.M., Yarasheski K.E. Exercise treatment to counteract protein wasting of chronic diseases. Curr Opin Clin Nutr Metab Care 2003, 6:87-93.
9. Yarasheski K.E. Exercise, aging, and muscle protein metabolism. J Gerontol A Biol Sci Med Sci 2003, 58(10):M918-M922.
10. Grutel M. The sarcomere and the nucleus: functional links to hypertrophy, atrophy and sarcopenia. Adv Exp Med Biol 2008, 642:176-191.
11. Favier F.B., Benoit H., Freyssenet D. Cellular and molecular events controlling skeletal muscle mass in response to altered use. Pflugers Arch 2008, 456:587-600.
12. Krusen's handbook of physical medicine and rehabilitation 1982, W.B. Saunders Co, Philadelphia. 3rd edition. F.J. Kottke, G.K. Stillwell, J.F. Lehman (Eds.).
13. Pieterse A.J., Luttikhold T.B., de Laat K., et al. Falls in patients with neuromuscular disorders. J Neurol Sci 2006, 251(1-2):87-90. [Epub 2006 Nov 9].
14. Aitkens S., Kilmer D.D., Wright N.C., et al. Metabolic syndrome in neuromuscular disease. Arch Phys Med Rehabil 2005, 86(5):1030-1036.
15. Skalsky A.J., Abresch R.T., Han J.J., et al. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 2008, 18(11):873-880. [Epub 2008 Sep 24].
16. Miller T.D., Balady G.J., Fletcher G.F. Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann Behav Med 1997, 19:220-229.
17. Fowler W.M. Importance of overwork weakness. Muscle Nerve 1984, 7(6):496-499.
18. Bennett R.L., Knowlton G.C. Overwork weakness in partially denervated skeletal muscle. Clin Orthop 1958, 12:22-92.
19. Johnson E.W., Braddom R. Over-work weakness in facioscapulohumeral dystrophy. Arch Phys Med Rehabil 1971, 52:333-362.
20. Pöche H., Kattner E., Hopfenmüller W. Myoglobinuria in hereditary progressive muscular dystrophies. Clin Physiol Biochem 1988, 6(6):334-339.
21. Doriguzzi C., Palmucci L., Mongini T., et al. Exercise intolerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy. J Neurol 1993, 240(5):269-271.
22. Figarella-Branger D., Baeta Machado A.M., Putzu G.A., et al. Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies. Acta Neuropathol 1997, 94(1):48-53.
23. Minetti C., Tanji K., Chang H.W., et al. Dystrophinopathy in two young boys with exercise-induced cramps and myoglobinuria. Eur J Pediatr 1993, 152(10):848-851.
24. Aitkens S.G., McCrory M.A., Kilmer D.D., et al. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993, 74:711-715.
25. Kilmer D.D., Aitkens S., Wright N.C., et al. Response to high-intensity eccentric muscle contractions in persons with myopathic disease. Muscle Nerve 2001, 24:1181-1187.
26. Milner-Brown H.S., Miller R.G. Muscle strengthening through high-resistance weight training in patients with neuromuscular disorders. Arch Phys Med Rehabil 1988, 69:14-19.
27. van der Kooi E.L., Lindeman E., Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2005, (1). CD003907.
28. Cup E.H., Pieterse A.J., Ten Broek-Pastoor J.M., et al. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil 2007, 88:1452-1464.
29. Dal Bello-Haas V., Florence J.M., Krivickas L.S. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2008, (2). CD005229.
30. White C.M., Pritchard J., Turner-Stokes L. Exercise for people with peripheral neuropathy. Cochrane Database Syst Rev 2004, (4). CD003904.
31. Ervasti J.M. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993, 122:809-823.
32. Franco A., Lansman J.B. Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 1990, 344:670-673.
33. Turner P.R., Fong P.Y., Denetclaw W.F., et al. Increased calcium influx in dystrophic muscle. J Cell Biol 1991, 115:1701-1712.
34. Stedman H.H., Sweeney H.L., Shrager J.B., et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539.
35. Clarkson P.M., Nosaka K., Braun B. Muscle function after exercise-induced muscle damage and rapid adaptation. Med Sci Sports Exerc 1992, 24:512-520.
36. Friden J., Lieber R.L. Structural and mechanical basis of exercise-induced muscle injury. Med Sci Sports Exerc 1992, 24:521-530.
37. Pasternak C., Wong S., Elson E.L. Mechanical function of dystrophin in muscle cells. J Cell Biol 1995, 128:355-361.
38. Petrof B.J. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 1998, 179(1-2):111-123.
39. Sander M., Chavoshan B., Harris S., et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2000, 97:13818-13823.
40. Kobayashi Y.M., Rader E.P., Crawford R.W., et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008, 456(7221):511-515. 26.
41. Vignos P.J., Watkins M.P. Effect of exercise in muscular dystrophy. JAMA 1966, 197:843-848.
42. Dubowitz V., Hyde S.A., Scott O.M., et al. Controlled trial of exercise in Duchenne muscular dystrophy. Neuromuscular diseases 1984, 571-575. Raven Press, New York. G. Serratrice (Ed.).
43. Scott O.M., Hyde S.A., Goddard C., et al. Effect of exercise in Duchenne muscular dystrophy: controlled six-month feasibility study of effects of two different regimes of exercises in children with Duchenne dystrophy. Physiotherapy 1981, 67:174-176.
44. DeLateur B.J., Giaconi R.M. Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 1979, 58:26-36.
45. Garrood M., Eagle P., Jardine K., et al. Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy. Neuromuscul Disord 2008, 18:71-73.
46. Kimura S., Ikezawa M., Nomura K., et al. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy. Brain Dev 2006, 28:473-476.
47. Vilozni D., Bar-Yishay E., Gur I., et al. Computerized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscul Disord 1994, 4:249-255.
48. Wanke T., Toifl K., Merkle M., et al. Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest 1994, 105:475-482.
49. Koessler W., Wanke T., Winkler G., et al. 2 years' experience with inspiratory muscle training in patients with neuromuscular disorders. Chest 2001, 120:765-769.
50. Martin A.J., Stern L., Yeates J., et al. Respiratory muscle training in Duchenne muscular dystrophy. Dev Med Child Neurol 1986, 28(3):314-318.
51. Gozal D., Thiriet P. Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception. Med Sci Sports Exerc 1999, 31:1522-1527.
52. Rodillo E., Noble-Jamieson C.M., Aber V., et al. Respiratory muscle training in Duchenne muscular dystrophy. Arch Dis Child 1989, 64:736-738.
53. Stern L.M., Martin A.J., Jones N., et al. Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Dev Med Child Neurol 1989, 31:494-500.
54. Smith P.E., Calverley P.M., Edwards R.H., et al. Practical considerations of respiratory care of patients with muscular dystrophy. N Engl J Med 1987, 316:1197-1205.
55. Sveen M.L., Jeppesen T.D., Hauerslev S., et al. Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 2008, 131:2824-2831.
56. Sveen M.L., Jeppesen T.D., Hauerslev S., et al. Endurance training: an effective and safe treatment of patients with LGMD2I. Neurology 2007, 68:59-61.
57. Yeldan I., Gurses H.N., Yuksel H. Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clin Rehabil 2008, 22(8):741-748.
58. Böhme P., Arnold C. Limb-girdle muscular dystrophy-results of physical therapy under stationary conditions. Aktuelle Neurologie 2004, 1:1-5.
59. Ansved T. Muscular dystrophies: influence of physical conditioning on the disease evolution. Curr Opin Clin Nutr Metab Care 2003, 6:435-439.
60. Wijmenga C., Frants R.R., Hewitt J.E., et al. Molecular genetics of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1993, 3:487-491.
61. Tawil R. Facioscapulohumeral muscular dystrophy. Neurotherapeutics 2008, 5(4):601-606.
62. Lemmer R., van der Vliet P.J., Klooster R., et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010, 329(5999):1650-1653.
63. Karpati G., Molnar M. Muscle fibre regeneration in skeletal muscle diseases. Skeletal muscle repair and regeneration 2008, 199-216. Springer Science, A.A. Dordrecht (The Netherlands). S. Schiaffino, T. Partridge (Eds.).
64. Van der Kooi E.L., Vogels O.J., Van Asseldonk R.J., et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 2004, 63(4):702-708.
65. Lindeman E., Leffers P., Spaans F., et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 1995, 76:612-620.
66. Olsen D.B., Orngreen M.C., Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 2005, 64:1064-1066.
67. Aldehag A.S., Jonsson H., Ansved T. Effects of a hand training programme in five patients with myotonic dystrophy type 1. Occup Ther Int 2005, 12:14-27.
68. Orngreen M.C., Olsen D.B., Vissing J. Aerobic training in patients with myotonic dystrophy type I. Ann Neurol 2005, 57:754-757.
69. Haller R.G., Wyrick P., Taivassalo T., et al. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol 2006, 59:922-928.
70. Maté-Muñoz J.L., Moran M., Pérez M., et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 2007, 17(4):297-303.
71. Pérez M., Foster C., González-Freire M., et al. One-year follow-up in a child with McArdle disease: exercise is medicine. Pediatr Neurol 2008, 38(2):133-136.
72. Pérez M., Maté-Muñoz J.L., Foster C., et al. Exercise capacity in a child with McArdle disease. J Child Neurol 2007, 22(7):880-882.
73. Ollivier K., Hogrel J.Y., Gomez-Merino D., et al. Exercise tolerance and daily life in McArdle's disease. Muscle Nerve 2005, 31(5):637-641.
74. Taivassalo T., Haller R.G. Exercise and training in mitochondrial myopathies. Med Sci Sports Exerc 2005, 37:2094-2101.
75. Taivassalo T., Matthews P.M., De Stefano N., et al. Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology 1996, 47(2):529-534.
76. Taivassalo T., De Stefano N., Argov Z., et al. Effects of aerobic training in patients with mitochondrial myopathies. Neurology 1998, 50:1055-1060.
77. Taivassalo T., De Stefano N., Chen J., et al. Short-term aerobic training response in chronic myopathies. Muscle Nerve 1999, 22:1239-1243.
78. Taivassalo T., Shoubridge E.A., Chen J., et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol 2001, 50(2):133-141.
79. Murphy J.L., Blakely E.L., Schaefer A.M., et al. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 2008, 131:2832-2840.
80. Siciliano G., Manca M.L., Renna M., et al. Effects of aerobic training on lactate and catecholaminergic exercise responses in mitochondrial myopathies. Neuromuscul Disord 2000, 10:40-45.
81. Taivassalo T., Gardner J.L., Taylor R.W., et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 2006 Dec, 129(Pt 12):3391-3401. [Epub 2006 Nov 3].
82. Jeppesen T.D., Schwartz M., Olsen D.B., et al. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 2006, 129:3402-3412.
83. Trenell M.I., Sue C.M., Kemp G.J., et al. Aerobic exercise and muscle metabolism in patients with mitochondrial myopathy. Muscle Nerve 2006, 33:524-531.
84. Askanas V., Engel W.K. Inclusion body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol 2007, 19(6):550-559.
85. Alexanderson H., Stenstrom C.H., Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology 1999, 38:608-611.
86. Alexanderson H., Lundberg I.E. The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol 2005, 17:164-171.
87. Alexanderson H., Stenstrom C.H., Jenner G., et al. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. Scand J Rheumatol 2000, 29:295-301.
88. Alexanderson H., Dastmalchi M., Esbjornsson-Liljedahl M., et al. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. Arthritis Rheum 2007, 57:766-777.
89. Alexanderson H. Exercise in inflammatory myopathies, including inclusion body myositis. Curr Rheumatol Rep 2012, 14(3):244-251.
90. Alexanderson H., Lundberg I.E. Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies. Curr Opin Rheumatol 2012, 24(2):201-207.
91. Wiesinger G.F., Quittan M., Nuhr M., et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000, 81:1-5.
92. Hicks J.E., Drinkard B., Summers R.M., et al. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002, 15:118-123.
93. Arnardottir S., Alexanderson H., Lundberg I.E., et al. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med 2003, 35:31-35.
94. Rosen D.R., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362(6415):59-62.
95. Kaspar B.K., Frost L.M., Christian L., et al. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 2005, 57:649-655.
96. Kirkinezos I.G., Hernandez D., Bradley W.G., et al. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003, 53(6):804-807.
97. Veldink J.H., Bär P.R., Joosten E.A., et al. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord 2003, 13(9):737-743.
98. Mahoney D.J., Rodriguez C., Devries M., et al. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve 2004, 29(5):656-662.
99. McCrate M.E., Kaspar B.K. Physical activity and neuroprotection in amyotrophic lateral sclerosis. Neuromolecular Med 2008, 10(2):108-117.
100. Drory V.E., Goltsman E., Reznik J.G., et al. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001, 191:133-137.
101. Bello-Haas V.D., Florence J.M., Kloos A.D., et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007, 68:2003-2007.
102. Jani-Acsadi A., Krajewski K., Shy M.E. Charcot-Marie-Tooth neuropathies: diagnosis and management. Semin Neurol 2008, 28:185-194.
103. Shy M.E., Chen L., Swan E.R., et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 2008, 70(5):378-383.
104. Chetlin R.D., Gutmann L., Tarnopolsky M., et al. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil 2004, 85:1217-1223.
105. El Mhandi L., Millet G.Y., Calmels P., et al. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease. Muscle Nerve 2008, 37:601-610.
106. Halsted L.S., Rossi C.D. New problems in old polio patients: results of a survey of 530 polio survivors. Orthopedics 1985, 8:845-850.
107. Halstead L.S., Gawne A.C. NRH proposal for limb classification and exercise prescription. Disabil Rehabil 1996, 18:311-316.
108. March of Dimes March of dimes international conference on post polio syndrome. Identifying best practices in diagnosis and care 2000, March of Dimes, White Plains (NY).
109. Farbu E., Gilhus N.E., Barnes M.P., et al. EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006, 13:795-801.
110. Chan K.M., Amirjani N., Sumrain M., et al. Randomized controlled trial of strength training in post-polio patients. Muscle Nerve 2003, 27:332-338.
111. Klein M.G., Whyte J., Esquenazi A., et al. A comparison of the effects of exercise and lifestyle modification on the resolution of overuse symptoms of the shoulder in polio survivors: a preliminary study. Arch Phys Med Rehabil 2002, 83:708-713.
112. Agre J.C., Rodriquez A.A., Franke T.M., et al. Low-intensity, alternate-day exercise improves muscle performance without apparent adverse affect in postpolio patients. Am J Phys Med Rehabil 1996, 78:50-62.
113. Prins J.H., Hartung H., Merritt D.J., et al. Effect of aquatic exercise training in persons with poliomyelitis disability. Sports Med Train Rehabil 1994, 5:29-39.
114. Agre J.C., Rodriquez A.A., Franke T.M. Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Arch Phys Med Rehabil 1997, 78:681-686.
115. Einarsson G. Muscle conditioning in late poliomyelitis. Arch Phys Med Rehabil 1991, 72:11-14.
116. Fillyaw M.J., Badger G.J., Goodwin G.D., et al. The effects of long-term non-fatiguing resistance exercise in subjects with post-polio syndrome. Orthopedics 1991, 14:1253-1256.
117. Spector S.A., Gordon P.L., Feuerstein I.M., et al. Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy. Muscle Nerve 1996, 19:1282-1290.
118. Jones D.R., Speier J., Canine K., et al. Cardiorespiratory responses to aerobic training by patients with postpoliomyelitis sequelae. JAMA 1989, 261:3255-3258.
119. Willén C., Sunnerhagen K.S., Grimby G. Dynamic water exercise in individuals with late poliomyelitis. Arch Phys Med Rehabil 2001, 82(1):66-72.
120. Ernstoff B., Wetterqvist H., Kvist H., et al. Endurance training effect on individuals with postpoliomyelitis. Arch Phys Med Rehabil 1996, 77:843-848.
121. Kriz J.L., Jones D.R., Speier J.L., et al. Cardiorespiratory responses to upper extremity aerobic training by postpolio subjects. Arch Phys Med Rehabil 1992, 73:49-54.
122. Dean E., Ross J. Effect of modified aerobic training on movement energetics in polio survivors. Orthopedics 1991, 14:1243-1246.
123. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscul Disord 2002, 12(10):975-983.
124. Bushby K., Finkel R., Birnkrant D.J., et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation and multidisciplinary care. Lancet Neurol 2010, 9(2):177-189. DMD Care Considerations Working Group, [Epub 2009 Nov 27].